BDBM434952 (1aR,2S,5R,5aR,6S,8aS,9R,10aR)-5,5a,6-trihydroxy-1,1,7,9-tetramethyl-4-(((5-(trifluoromethyl)pyrimidin-2-yl)oxy)methyl)-1a,2,5,5a,6,9,10,10a-octahydro-1H-2,8a-methanocyclopenta[a]cyclopropa[e][10]annulen-11-one::US10583140, Example 12

SMILES CC1=C[C@]23C(=O)[C@@H](C=C(COc4ncc(C(F)(F)F)cn4)[C@@H](O)[C@]2(O)[C@H]1O)[C@H]1[C@@H](C[C@H]3C)C1(C)C

InChI Key InChIKey=XNFMJVPAJZYKFR-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 434952   

TargetGag-Pol polyprotein(HIV-1)
Glaxosmithkline Intellectual Property Development

US Patent
LigandChemical structure of BindingDB Monomer ID 434952BDBM434952(US10583140, Example 12 | (1aR,2S,5R,5aR,6S,8aS,9R,...)
Affinity DataEC50:  5.17E+3nMAssay Description:For the Jurkat HIV Latency assay, compounds are dissolved and titrated in DMSO and diluted 100-fold in assay medium (RPMI-1640 containing 10% fetal b...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2020
Entry Details Article
US Patent